Pfizer wil_老虎社区_美港股上老虎

2022-01-06

Pfizer will be a surefire winner in 2022 as a company regardless of what happens with the COVID-19 pandemic. It already has major supply deals lined up for its COVID-19 vaccine and pill that will generate billions of dollars in revenue. Pfizer's lineup also includes multiple other growth drivers like blood thinner Eliquis and rare heart disease drug Vyndaqel/Vyndamax. $Pfizer(PFE)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":695642882,"tweetId":"695642882","gmtCreate":1641455705291,"gmtModify":1641456765338,"author":{"id":3479274781436276,"authorId":3479274781436276,"authorIdStr":"3479274781436276","name":"BecauseOfYou","avatar":"https://static.laohu8.com/picture117","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Pfizer will be a surefire winner in 2022 as a company regardless of what happens with the COVID-19 pandemic. It already has major supply deals lined up for its COVID-19 vaccine&nbsp;and pill that will generate billions of dollars in revenue. Pfizer's lineup also includes multiple other growth drivers like blood thinner Eliquis and rare heart disease drug&nbsp;Vyndaqel/Vyndamax.&nbsp;<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a> </body></html>","htmlText":"<html><head></head><body>Pfizer will be a surefire winner in 2022 as a company regardless of what happens with the COVID-19 pandemic. It already has major supply deals lined up for its COVID-19 vaccine&nbsp;and pill that will generate billions of dollars in revenue. Pfizer's lineup also includes multiple other growth drivers like blood thinner Eliquis and rare heart disease drug&nbsp;Vyndaqel/Vyndamax.&nbsp;<a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a> </body></html>","text":"Pfizer will be a surefire winner in 2022 as a company regardless of what happens with the COVID-19 pandemic. It already has major supply deals lined up for its COVID-19 vaccine and pill that will generate billions of dollars in revenue. Pfizer's lineup also includes multiple other growth drivers like blood thinner Eliquis and rare heart disease drug Vyndaqel/Vyndamax. $Pfizer(PFE)$","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/695642882","repostId":0,"isVote":1,"tweetType":1,"viewCount":1185,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":325,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/695642882"}